🔎 Trials Near Me

Home › Burkitt Lymphoma › Iowa › Des Moines

Burkitt Lymphoma clinical trials in Des Moines, IA

5 studies for Burkitt Lymphoma are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

RecruitingPhase 2
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive · 6 mi away
  • and 2 more
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 2
  • Blank Children's Hospital, Des Moines
Ages 1 to 30 · All sexes · Updated Nov 12, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Blank Children's Hospital, Des Moines
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Burkitt Lymphoma trials in other cities

Other studies in Des Moines

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.